Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium chloride (KCl) replaces potassium ions, which are essential for maintaining cellular membrane potential, nerve impulse transmission, muscle contraction, and acid-base balance. Dextrose 5% provides a source of calories and water for hydration.
Potassium chloride dissociates to potassium ions, which are essential for maintaining intracellular tonicity, nerve impulse conduction, muscle contraction, and acid-base balance. Replacement therapy corrects hypokalemia and prevents potassium deficiency.
10-20 mEq potassium chloride IV infused at a rate not exceeding 10-20 mEq/hour; maximum 40 mEq per dose. Administer in dextrose 5% solution.
10-20 mEq/h IV, not exceeding 20 mEq/h; concentration ≤ 0.2 mEq/mL. Typical total daily dose 40-100 mEq, depending on serum potassium.
None Documented
None Documented
Potassium has no classic elimination half-life; distribution and excretion are rapid with a plasma half-life of approximately 1–1.5 hours in healthy individuals, but this is clinically irrelevant as body stores are regulated by renal function.
Not applicable (endogenous ion); distribution half-life ~1-1.5 h with normal renal function.
Renal: >90% of potassium is excreted renally, primarily via distal tubular secretion; a small fraction is lost in feces (<10%) and negligible biliary elimination.
Renal: >90% as potassium ions, with small fecal loss; no biliary elimination.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher